Digital RESI Pitch Session

Interested in Connecting? Please contact:
Arkadiusz Z. Dudek, MD, PhD
President and CEO

Message the company or request a 1:1 meeting here

TTC Oncology LLC is developing a novel, small-molecule therapy to address unmet needs of patients with metastatic breast cancer that failed to respond to hormonal therapy and CDK4/6 inhibitor. Founded in July 2015, TTC Oncology has completed phase I trial at four clinical sites under the guidance of breast cancer oncologists and consultants with extensive experience in pharma and biotech.

Pitch Video